miophthalmology products

Wavelight Plus

Wavelight plus* is the first fully tailored refractive treatment that accounts for the unique optical system of each person, including the cornea, anterior chamber, and crystalline lens.1 The wavelight plus all-in-one sightmap diagnostic device combines biometry, tomography, and wavefront to create a virtual three-dimensional eye model and individualised treatment plan.1 Even complex cases can now achieve better than 20/20 vision,2 unlocking a new world of possibilities for both patients and surgeons.

Contact: Alcon Account Manager

*Wavelight plus is the alternative equivalent tradename for InnovEyes treatment.

References
1. Mrochen, M., Bueler, M., Donitzky, C., Seiler, T., Optical ray tracing for the calculation of optimized corneal ablation profiles in refractive treatment planning. J Refract Surg. 2008;24:S446–S451.
2. Alcon data on file, 2021. RFP911-P001 Postmarket study of outcomes from
waveLight EX500 InnovEyes – V-RIM-0063613.
ANZ-IVS-2400002

Lenstar Myopia

Introduce or expand your myopia management capabilities with precise measurements for early detection of myopia onset and state-of-the-art myopia management.

Haag-Streit’s Lenstar Myopia uses the latest automated positioning technology for a fully automated measurement capture process, combined with graphical data from Erasmus University to detect, track progression, and communicate treatment pathways effectively with patients and parents.

The Lenstar Myopia is highly accurate and repeatable, averaging multiple individual measurements for axial length measurement, enabling practitioners to identify true progression from deviation. In addition, the Haag-Streit age matched myopia control software makes management easy by adding a ‘traffic light’ system to next required steps. Networkable with existing practice IT ecosystems, and chair and stand compatible, Lenstar Myopia is easily integrated into
the practice, even for the space conscious.

Contact: Device Technologies (AUS) 1300 338 423

Topcon Myah

Topcon’s Myah offers all the technologies required to support myopia management: optical biometry, corneal topography, and pupillometry. Additionally, Myah is an all-in-one device that offers an evolving platform of tools to add or grow dry eye management to any practice.

Myah’s fully featured onboard software system allows the user to review, diagnose, and track a variety of ocular conditions, from complex contact lens fitting applications to the latest in minimally invasive dry eye diagnostic analysis.

Additionally, the myopia module combines highly accurate and repeatable axial length measurement facilities with detailed reporting, and growth curve software tools to professionally manage myopia, as well as communicate effectively with patients and parents. Networkable, and chair and stand compatible, it enables easy practice integration. The large colour touchscreen allows for an easy measurement capture process.

Contact: Device Technologies (AUS) 1300 338 423

Oculus Myopia Master

The Oculus Myopia Master measures three key parameters to help make myopia detection and management easier and more reliable. Measurement of refraction, axial length, and keratometry in a stylish unit, delivered with a comprehensive myopia software suite, helps provide clarity of diagnoses. Additionally, it presents selected action recommendations and progression diagrams in an intuitive way. The new growth control module shows changes in eye growth as well as treatment successes.

The Oculus Myopia Master is the only device to incorporate the latest Brien Holden Vision Institute (BHVI) data for estimating future myopia progression, enabling personalised reports detailing a child’s current myopia status and their likely outcome in adulthood. BHVI’s data sets, with diverse strata of age, gender, and ethnicity, improve modelling in a wider patient cohort and enhance parent counselling – giving practitioners confidence without compromise.

Contact: Designs for Vision (AUS) 1800 225 307

Repeated Low-Level Red-Light Therapy

Eyerising’s repeated low-level red-light (RLRL) device for myopia management uses patented technology to gently stimulate blood flow in the ocular fundus. The device is designed to alleviate scleral hypoxia and control axial lengthening.

One of the key advantages of this therapy is convenience – it takes just three minutes, twice a day, five days a week of therapy at home. Additionally, a simple touchscreen control makes it suitable for children as young as three years old.

The device has a good safety record and profile, is simple to use, non-invasive, and clinically proven to be effective.1

Visit: eyerisinginternational.com

Reference
1. Aung, Y., and Gifford, K., Global insights on repeated low-level red-light therapy for myopia. mivision issue 203, August 2024, P. 65-67.

Cylite

Australian hyperparallel optical coherence tomography (HP-OCT) manufacturer Cylite will be integrating the PreMO app into its software and it will be made available to all new and existing users.

PreMO (predicting myopia onset and progression) is evidence-based myopia risk indicator software developed by world renowned expert, Professor James Wolffsohn from Aston University, and based on research conducted by colleagues at Ulster University. The app uses spherical equivalent refraction, axial length, and parental myopia status to stratify the future risk of developing myopia as well as its progression once myopia has developed.

The app presents axial length for individual patients against predictive growth curves, as well as predicting at what age they will become myopic and how fast they will progress.

Visit: cyliteoptics.com